FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

CDRH Sets Marketing Authorization Record

The CDRH 2023 annual report says the Center approved the most novel devices in its history.

latest-news-card-1
Human Drugs

U.S. Reassures Canada on Drug Imports

Canada health minister Mark Holland says he has been assured by top U.S. officials that the U.S. does not intend to harm Canadas drug supply by approv...

latest-news-card-1
Medical Devices

IVD Director Timothy Stenzel Retires

CDRH Office of In Vitro Diagnostics director Timothy Stenzel retires after almost six years as head of diagnostic devices.

latest-news-card-1
Human Drugs

Package Level Drug Distribution Security Guidance

FDA publishes a guidance on enhanced drug distribution security at the package level.

latest-news-card-1
Human Drugs

Satsuma Complete Response on Migraine Drug

FDA sends Satsuma Pharmaceuticals a complete response letter on its NDA for STS101 (dihydroergotamine nasal powder), an investigational product for th...

latest-news-card-1
Medical Devices

Percussionaire Recalls Ventilator Part

Percussionaire recalls its Distal Phasitron, part: S20020, for use with the Percussionaire VDR-4 ventilator control driver due to the potential for th...

latest-news-card-1
Medical Devices

Megadyne Mega Soft Electrode Recall is Class 1

FDA says the Megadyne recall of four models of patient return electrodes following reports of patient burns is Class 1.

latest-news-card-1
Medical Devices

GAO Probing FDA Ventilator Recall Actions

The Pittsburgh Post-Gazette says GAO has accepted a request from two senators to look into FDA oversight of medical device adverse events and recalls.

latest-news-card-1
Medical Devices

Reducing the Potential for Pulse Oximeter Bias

Two stakeholders raise concerns about an FDA discussion paper on guidelines for pulse oximeters that consider skin pigmentation, race, and ethnicity.

latest-news-card-1

FDA Needs Help in Regulating Algorithms: Califf

FDA commissioner Robert Califf says FDA needs to work within a community of organizations assessing and evaluating artificial intelligence adaptive to...